Medicines on the FDA drug shortage list, with which forms and strengths are affected, who makes them and when supply is expected back.
91 medicines
-
Methylphenidate In shortage 4 products · updated October 16, 2026
Psychiatry
Product Availability Expected supply / notes Methylphenidate, Film, Extended Release, 20 mg (NDC 0574-2420-65)
Noven Pharmaceuticals, Inc.Available Distributed by Padagis US LLC
In shortage · October 16, 2026Methylphenidate, Film, Extended Release, 10 mg (NDC 0574-2410-65)
Noven Pharmaceuticals, Inc.Available Distributed by Padagis US LLC
In shortage · October 16, 2026Methylphenidate, Film, Extended Release, 15 mg (NDC 0574-2415-65)
Noven Pharmaceuticals, Inc.Available Distributed by Padagis US LLC
In shortage · October 16, 2026Methylphenidate, Film, Extended Release, 30 mg (NDC 0574-2430-65)
Noven Pharmaceuticals, Inc.Available Distributed by Padagis US LLC
In shortage · October 16, 2026 -
Technetium Tc 99m Pyrophosphate In shortage Limited supply 1 product · updated October 16, 2026
Medical Imaging
Product Availability Expected supply / notes Technescan PYP, Injection, 11.9 mg/10 mL; 3.2 mg/10 mL (NDC 69945-094-20)
Curium US LLCLimited On allocation
In shortage · October 16, 2026 -
Bupivacaine Hydrochloride and Epinephrine Bitartrate In shortage Some forms unavailable 8 products · updated October 15, 2026
Anesthesia
Product Availability Expected supply / notes Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-31)
Fresenius Kabi USA, LLCUnavailable Estimated recovery: TBD
In shortage · October 15, 2026Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-461-57)
Fresenius Kabi USA, LLCUnavailable Next release November 2026. Check wholesalers for inventory.
In shortage · October 15, 2026Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-463-57)
Fresenius Kabi USA, LLCUnavailable Next release October 2026. Check wholesalers for inventory.
In shortage · October 15, 2026+ 5 more products listed, currently available.
-
Conivaptan Hydrochloride In shortage Some forms unavailable 1 product · updated October 15, 2026
Cardiovascular
Product Availability Expected supply / notes Vaprisol Dextrose In Plastic Container, Injection, 20 mg/100 mL (NDC 66220-160-10)
Cumberland Pharmaceuticals Inc.Unavailable Estimated recovery: TBD
In shortage · October 15, 2026 -
Desmopressin Acetate In shortage Some forms unavailable 4 products · updated October 15, 2026
Hematology
Product Availability Expected supply / notes Stimate, Spray, 1.5 mg/1 mL (NDC 0053-6871-00)
FerringUnavailable Estimated recovery: TBD
In shortage · May 1, 2026Ddavp, Spray, .1 ug/1 mL (NDC 55566-2500-0)
FerringUnavailable Estimated recovery: TBD
In shortage · May 1, 2026Desmopressin Acetate, Spray, 10 ug/.1 mL (NDC 69918-501-05)
FerringUnavailable Estimated recovery: TBD
In shortage · May 1, 2026Desmopressin Acetate (needs No Refrigeration), Spray, 10 ug (NDC 60505-0815-0)
Apotex Corp.Limited Replenishment expected mid to late November 2026
In shortage · October 15, 2026 -
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate In shortage Some forms unavailable 7 products · updated October 15, 2026
Psychiatry
Product Availability Expected supply / notes Adderall, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 57844-112-01)
Teva Pharmaceuticals USA, Inc.Unavailable Estimated recovery: November 2026
In shortage · October 15, 2026+ 6 more products listed, currently available.
-
Lidocaine Hydrochloride,epinephrine Bitartrate In shortage Some forms unavailable 10 products · updated October 15, 2026
Anesthesia, Pediatric
Product Availability Expected supply / notes Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-17)
Fresenius Kabi USA, LLCUnavailable Next release November 2026. Check wholesalers for inventory.
In shortage · October 15, 2026Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57)
Fresenius Kabi USA, LLCUnavailable Next release October 2026. Check wholesalers for inventory.
In shortage · October 15, 2026Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-27)
Fresenius Kabi USA, LLCUnavailable Next release October 2026. Check wholesalers for inventory.
In shortage · October 15, 2026+ 7 more products listed, currently available.
-
Methotrexate Sodium In shortage 2 products · updated October 15, 2026
Rheumatology, Oncology
Product Availability Expected supply / notes Methotrexate Preservative Free, Injection, 1 g (NDC 63323-122-50)
Fresenius Kabi USA, LLCAvailable Check wholesaler for inventory
In shortage · October 15, 2026Methotrexate Sodium, Injection, 25 mg/1 mL (NDC 63323-123-10)
Fresenius Kabi USA, LLCAvailable Check wholesaler for inventory
In shortage · October 15, 2026 -
Propranolol Hydrochloride In shortage Some forms unavailable 2 products · updated October 15, 2026
Cardiovascular
Product Availability Expected supply / notes Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-604-01)
Fresenius Kabi USA, LLCUnavailable Next release: November 2026. Check wholesalers for inventory.
In shortage · October 15, 2026Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 0143-9872-10)
Hikma Pharmaceuticals USA, Inc.Unavailable Estimated recovery: TBD
In shortage · October 14, 2026 -
Riluzole In shortage Some forms unavailable 4 products · updated October 15, 2026
Neurology
Product Availability Expected supply / notes Tiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-1)
EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)Unavailable Estimated recovery: TBD
In shortage · October 15, 2026+ 3 more products listed, currently available.
-
Streptozocin Powder, For In shortage Some forms unavailable 2 products · updated October 15, 2026
Oncology
Product Availability Expected supply / notes Zanosar, Powder, For Solution, 100 mg/1 mL (NDC 0703-4636-01)
Teva Pharmaceuticals USA, Inc.Unavailable Estimated recovery: TBD
In shortage · October 15, 2026+ 1 more product listed, currently available.
-
Valproate Sodium In shortage Some forms unavailable 2 products · updated October 15, 2026
Neurology
Product Availability Expected supply / notes Valproate Sodium, Injection, 100 mg/1 mL (NDC 63323-494-05)
Fresenius Kabi USA, LLCUnavailable Next release November 2026. Check wholesalers for inventory.
In shortage · October 15, 2026+ 1 more product listed, currently available.
-
Cefotaxime In shortage Some forms unavailable 6 products · updated October 14, 2026
Anti-Infective, Pediatric
Product Availability Expected supply / notes Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 0143-9933-25)
Hikma Pharmaceuticals USA, Inc.Unavailable Estimated recovery: TBD
In shortage · October 14, 2026Cefotaxime Sodium, Powder, for Solution, 10 g (NDC 0143-9935-01)
Hikma Pharmaceuticals USA, Inc.Unavailable Estimated recovery: TBD
In shortage · October 14, 2026Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10)
Hikma Pharmaceuticals USA, Inc.Unavailable Estimated recovery: TBD
In shortage · October 14, 2026Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 0143-9931-25)
Hikma Pharmaceuticals USA, Inc.Unavailable Estimated recovery: TBD
In shortage · October 14, 2026+ 2 more products listed, currently available.
-
Liraglutide In shortage Limited supply 9 products · updated October 14, 2026
Endocrinology/Metabolism
Product Availability Expected supply / notes Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12)
Novo Nordisk, Inc.Limited Estimated shortage duration: TBD
In shortage · September 22, 2026Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15)
Novo Nordisk, Inc.Limited Product will be available until discontinuation in January 2027
In shortage · September 22, 2026Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13)
Novo Nordisk, Inc.Limited Estimated shortage duration: TBD
In shortage · September 22, 2026+ 6 more products listed, currently available.
-
Midazolam In shortage 5 products · updated October 14, 2026
Anesthesia, Neurology
Product Availability Expected supply / notes Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6057-25)
Hikma Pharmaceuticals USA, Inc.Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.
In shortage · October 14, 2026Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6061-25)
Hikma Pharmaceuticals USA, Inc.Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.
In shortage · October 14, 2026Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6059-01)
Hikma Pharmaceuticals USA, Inc.Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.
In shortage · October 14, 2026Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6056-10)
Hikma Pharmaceuticals USA, Inc.Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.
In shortage · October 14, 2026Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6060-10)
Hikma Pharmaceuticals USA, Inc.Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.
In shortage · October 14, 2026 -
Promethazine Hydrochloride In shortage Some forms unavailable 10 products · updated October 14, 2026
Analgesia/Addiction, Gastroenterology, Pediatric, Pulmonary/Allergy, Other
Product Availability Expected supply / notes Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-1495-35)
Hikma Pharmaceuticals USA, Inc.Unavailable Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released.
In shortage · October 14, 2026Phenergan, Injection, 50 mg/1 mL (NDC 0641-6085-25)
Hikma Pharmaceuticals USA, Inc.Unavailable Estimated recovery: TBD
In shortage · October 14, 2026Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-0929-25)
Hikma Pharmaceuticals USA, Inc.Unavailable Estimated recovery: TBD
In shortage · October 14, 2026Phenergan, Injection, 25 mg/1 mL (NDC 0641-6084-25)
Hikma Pharmaceuticals USA, Inc.Unavailable Estimated recovery: TBD
In shortage · October 14, 2026Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 39822-5550-6)
XGen Pharmaceuticals DJB, Inc.Unavailable Estimated recovery: TBD
In shortage · September 22, 2026+ 5 more products listed, currently available.
-
Quinapril In shortage Some forms unavailable 11 products · updated October 13, 2026
Cardiovascular
Product Availability Expected supply / notes Quinapril Hydrochloride, Tablet, 20 mg (NDC 68180-558-09)
Lupin Pharmaceuticals, Inc.Unavailable Estimated recovery: TBD
In shortage · October 13, 2026Quinapril Hydrochloride, Tablet, 40 mg (NDC 68180-554-09)
Lupin Pharmaceuticals, Inc.Unavailable Estimated recovery: TBD
In shortage · October 13, 2026Quinapril Hydrochloride, Tablet, 10 mg (NDC 68180-557-09)
Lupin Pharmaceuticals, Inc.Unavailable Estimated recovery: TBD
In shortage · October 13, 2026Quinapril Hydrochloride, Tablet, 5 mg (NDC 43547-410-09)
Solco Healthcare US, LLCUnavailable Not available. Long-term backorder for all NDCs. No estimated release date at this time.
In shortage · June 29, 2026Quinapril Hydrochloride, Tablet, 20 mg (NDC 43547-412-09)
Solco Healthcare US, LLCUnavailable Not available. Long-term backorder for all NDCs. No estimated release date at this time.
In shortage · June 29, 2026Quinapril Hydrochloride, Tablet, 40 mg (NDC 43547-413-09)
Solco Healthcare US, LLCUnavailable Not available. Long-term backorder for all NDCs. No estimated release date at this time.
In shortage · June 29, 2026Quinapril Hydrochloride, Tablet, 10 mg (NDC 43547-411-09)
Solco Healthcare US, LLCUnavailable Not available. Long-term backorder for all NDCs. No estimated release date at this time.
In shortage · June 29, 2026+ 4 more products listed, currently available.
-
Quinapril Hydrochloride In shortage Some forms unavailable 5 products · updated October 13, 2026
Cardiovascular
Product Availability Expected supply / notes Quinapril Hydrochloride, Tablet, 5 mg (NDC 68180-556-09)
Lupin Pharmaceuticals, Inc.Unavailable Estimated recovery: TBD
In shortage · October 13, 2026Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90)
Aurobindo Pharma USAUnavailable Discontinuation of the manufacture of the drug
In shortage · October 2, 2026Quinapril Hydrochloride, Tablet, 5 mg (NDC 65862-617-90)
Aurobindo Pharma USAUnavailable Discontinuation of the manufacture of the drug
In shortage · October 2, 2026Quinapril Hydrochloride, Tablet, 40 mg (NDC 65862-620-90)
Aurobindo Pharma USAUnavailable Discontinuation of the manufacture of the drug
In shortage · October 2, 2026Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90)
Aurobindo Pharma USAUnavailable Discontinuation of the manufacture of the drug
In shortage · October 2, 2026 -
Lidocaine Hydrochloride Anhydrous In shortage Some forms unavailable 1 product · updated October 8, 2026
Anesthesia
Product Availability Expected supply / notes Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 65282-1605-1)
Spectra Medical Devices, LLCUnavailable Estimated recovery: TBD
In shortage · October 8, 2026 -
Quinapril and Hydrochlorothiazide In shortage 3 products · updated October 2, 2026
Cardiovascular
Product Availability Expected supply / notes Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 62135-668-90)
Chartwell Molecular Holdings LLCAvailable —
In shortage · October 2, 2026Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 62135-667-90)
Chartwell Molecular Holdings LLCAvailable —
In shortage · October 2, 2026Quinapril/Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 62135-669-90)
Chartwell Molecular Holdings LLCAvailable —
In shortage · October 2, 2026 -
Quinapril Hydrochloride/Hydrochlorothiazide In shortage Some forms unavailable 3 products · updated October 2, 2026
Cardiovascular
Product Availability Expected supply / notes Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 65862-163-90)
Aurobindo Pharma USAUnavailable Discontinuation of the manufacture of the drug
In shortage · October 2, 2026Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 65862-162-90)
Aurobindo Pharma USAUnavailable Discontinuation of the manufacture of the drug
In shortage · October 2, 2026Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 65862-161-90)
Aurobindo Pharma USAUnavailable Discontinuation of the manufacture of the drug
In shortage · October 2, 2026 -
Cromolyn Sodium Concentrate In shortage Limited supply 2 products · updated September 30, 2026
Pulmonary/Allergy
Product Availability Expected supply / notes Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 69784-200-96)
Ailex PharmaceuticalsLimited No longer manufactured, some supplies still available in supply chain. Distributed by Woodward Pharma Services LLC (248) 308-1120 Ext 2
In shortage · September 30, 2026Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 76204-025-96)
Ailex PharmaceuticalsLimited No longer manufactured, some supplies still available in supply chain. Distributed by Ritedose Pharmaceuticals, LLC (855) 806 3300
In shortage · September 30, 2026 -
Flurazepam Hydrochloride In shortage Some forms unavailable 6 products · updated September 15, 2026
Oncology, Other, Neurology
Product Availability Expected supply / notes Flurazepam Hydrochloride, Capsule, 30 mg (NDC 0378-4430-01)
Rising Pharma Holdings, Inc.Unavailable Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.
In shortage · September 1, 2026Flurazepam Hydrochloride, Capsule, 15 mg (NDC 0378-4415-01)
Rising Pharma Holdings, Inc.Unavailable Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.
In shortage · September 1, 2026+ 4 more products listed, currently available.
-
Penicillin G Benzathin In shortage 1 product · updated September 15, 2026
Anti-Infective
Product Availability Expected supply / notes Lentocilin, Injection, 1200000 U/4 mL (NDC 84383-110-01)
Laboratorios AtralAvailable —
In shortage · September 15, 2026 -
Rocuronium In shortage Limited supply 2 products · updated September 15, 2026
Anesthesia
Product Availability Expected supply / notes Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 66794-229-41)
Piramal Critical Care Inc.Limited On allocation
In shortage · September 15, 2026+ 1 more product listed, currently available.
-
Triamcinolone Hexacetonide In shortage 1 product · updated September 15, 2026
Rheumatology
Product Availability Expected supply / notes Hexatrione, Injection, 40 mg/2 mL (NDC 59137-570-01)
MedexusAvailable —
In shortage · September 15, 2026 -
Ifosfamide For In shortage 1 product · updated September 8, 2026
Oncology, Pediatric
Product Availability Expected supply / notes Ifosfamide, Injection, 1 g/1 (NDC 21586-211-02)
SteriMax, Inc.Available To place an order, please contact GlobalRX at info@globalrx.com or (919) 245-8418
In shortage · September 8, 2026 -
Echothiophate Iodide For In shortage 1 product · updated September 1, 2026
Ophthalmology
Product Availability Expected supply / notes Phospholine Iodide, Ophthalmic Solution, 0.125% (NDC 48102-053-05)
Fera PharmaceuticalsAvailable Available through limited distribution by Walgreens Specialty Pharmacy.
In shortage · September 1, 2026 -
Hydralazine Hydrochloride In shortage 1 product · updated August 27, 2026
Cardiovascular
Product Availability Expected supply / notes Furosemide, Injection, 10 mg/mL, 2 mL (NDC 71288-205-03)
Meitheal Pharmaceuticals, Inc.Available Check wholesalers for inventory
In shortage · August 27, 2026 -
Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate In shortage Limited supply 6 products · updated August 20, 2026
Psychiatry
Product Availability Expected supply / notes Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0406-8894-01)
SpecGx LLCLimited Estimated recovery: TBD
In shortage · August 20, 2026Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0406-8892-01)
SpecGx LLCLimited Estimated recovery: TBD
In shortage · August 20, 2026Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0406-8891-01)
SpecGx LLCLimited Estimated recovery: TBD
In shortage · August 20, 2026+ 3 more products listed, currently available.
Reading the list: a medicine stays on the FDA list while any of its products is short. "Available" next to a product means that particular strength or pack can currently be ordered. If your pharmacy cannot fill a prescription, ask the pharmacist or prescriber about another strength, form or an alternative — do not ration or stop a medicine on your own.
Source: FDA Drug Shortages Database, via openFDA. Updated here twice a day; last update October 31, 2026 14:40. openFDA data are not validated for clinical use — confirm with the FDA source or your pharmacist.